Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer

Clinical trial NCT02550327 · COMPLETED

Trial details

NCT number: NCT02550327
Sponsor: Baylor Research Institute
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma

Start date: 2016-01-01
Primary completion: 2021-06-14
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.